The North America dry eye syndrome market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.89% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 2.8 Billion |
Market Forecast in 2033
|
USD 4.4 Billion |
Market Growth Rate 2025-2033 | 4.89% |
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.
North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.
IMARC Group provides an analysis of the key trends in each segment of the North America dry eye syndrome market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Disease Type, Drug Type, Product, Distribution Channel, Country |
Countries Covered | United States, Canada |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report: